Blog Voices from the Frontlines
In the February 2018 Issue:
- Federal Budget Impasse Again Imperils Patient Protections
- DOJ Action Spurs New Support for Legislation in Congress
- VA Rejects Congressional Pressure on Cannabis Studies
- Virginia Advocates Help Pave Way to Historic Bill
- ASA Training and Education Programs Range from Raid Prep to CME
- Registration Opens for 2018 National Unity Conference
- Remembering Dennis Peron
- ASA Activist Profile: Scott Roberts, Sacramento, California
- ACTION ALERT: Protect Medical Cannabis Patients!
Bill Allowing All Physicians to Recommend Cannabis Oils Passes House and Senate
Richmond VA — Today, the Virginia General Assembly Senate passed SB726 by a vote of 40 to 0. Last week, the companion bill passed the House of Delegates unanimously by a vote of 98-0. The bill will allow physicians to recommend cannabidiol (CBD) and tetrahydrocannabinolic acid (THC-A) oils to any patients for whom they feel the oils could help their conditions. Last year, the General Assembly passed legislation permitting the cultivation and manufacturing of cannabis oils for up to five processors in the state, but the only condition permitted was intractable epilepsy.
“I’m not giving up until everybody has what they need,” - Beth Collins
The medical cannabis community is mourning the death of medical cannabis pioneer Dennis Peron, who died on Saturday at the age of seventy-two. Dennis was the founder of the legendary San Francisco Cannabis Buyers Club in San Francisco and a crusader for the right to safe access to medical cannabis in California.
Called the “Father of Medical Marijuana,” he inspired the grassroots movement that adopted Proposition 215 legalizing medical cannabis in California in 1996.
Valley delegate introduces bill expanding the uses of medical cannabis oil - Americans for Safe Access
By Marina Barnett for WHSV3
Beth Collins, who is a Senior Director of Government Relations and External Affairs at Americans for Safe Access, said cannabis oil was the last option for her daughter, who suffers from epilepsy. She wants this bill to help other patients who are struggling with symptoms to get the help they need as well. The new bill lets doctors make that decision, instead of lawmakers.
"We just don't think that's a good approach for anybody, or fair, so we wanted to let doctors decide and Senator Dunnavant agreed to submit the bill," said Collins.
This Week's Volunteer Needs
Please comment below if you are interested in helping, or if you have completed any of the following:
By Rebecca Trager for Chemistry World
‘For a lot of people who are in the medical cannabis space, this is one of their biggest fears about Sessions – that he would rescind the non-interference cannabis policies of Obama,’ - Jahan Marcu
The Congressional Research Service (CRS) released a memorandum analyzing the Justice Department’s Decision to rescind Obama-era guidance on federal cannabis policy including the Cole Memo, the Ogden Memos, the Wilkinson memo on cannabis on tribal lands and the FinCen guidance which created policies for financial institutions interacting with cannabis businesses. CRS is a non-partisan office in the Library of Congress that provides legislative advice and analysis to both parties in a neutral way.
In the January 2018 Issue
- DOJ Memo on Prosecutions Rescinded; Temporary Protections Remain
- ASA Launches Campaign on Cannabis as a Tool in Opioid Crisis
- Veterans Administration Loosens Cannabis Policy
- WHO Initial Report Says CBD Needs No Restrictions
- DEA Yields to Pressure, Removes Misinformation on Cannabis
- ASA National Unity Conference a Success
- ASA’s Annual Report on State Medical Cannabis Programs Finds Improvements
- State & International Developments
- ASA’s Training Programs Going Global
- ACTION ALERT: Send Congress Your Story Today!
By Beryl Lieff Benderly for Science Magazine
Growing up with a close relative who used marijuana before legalization to alleviate symptoms of a medical condition inspired [Dr. Jahan] Marcu’s fascination with the plant’s relationship to the human body. Having researched cannabinoids’ anticancer activity as a technician and the structure, function, and signaling of cannabinoid receptors, especially in bone, for his Ph.D. dissertation, he now focuses on developing and implementing recognized, science-based standards to assure that the medicine sold is safe, pure, and what it purports to be.